Paricalcitol

Paricalcitol on the U.S. market: products, makers and brands

How Paricalcitol appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

11 companies list 39 Paricalcitol product records with the FDA, mostly as capsule, injection; the earliest marketing or approval year on record is 1998. Brand names on the directory include Zemplar; the rest are generics.

Also listed with the FDA, not a patient dose form: Powder (6) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

How widely Paricalcitol is used (Medicaid data)

A general measure of how commonly Paricalcitol is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Paricalcitol is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

How commonly is Paricalcitol prescribed? Of the 1,601 medications we measure, Paricalcitol ranks #480 by Medicaid prescriptions — more than 70% of them.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Paricalcitol, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 12 of 74 listed Paricalcitol NDCs with Medicaid activity.

Compare Paricalcitol products

A representative set of FDA-listed product records for Paricalcitol — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 39 of 39 products — FDA National Drug Code Directory. See every product, package size and price: browse all 39 Paricalcitol NDCs →

Paricalcitol brand names

Paricalcitol is sold under one brand name in the FDA directory — Zemplar. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.

Who makes Paricalcitol: manufacturers and labelers

11 companies list Paricalcitol products with the FDA. By number of product records, the largest are Amneal Pharmaceuticals LLC, AbbVie Inc., Bryant Ranch Prepack. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Paricalcitol compared with similar medicines

Medicines in the same class as Paricalcitol that we cover: Ergocalciferol, Doxercalciferol. The table compares what the FDA directory records for each — how it is sold, the dose forms on the market, how many companies list it (makers, repackagers and distributors), and the earliest FDA record on file. Same class does not mean interchangeable; your prescriber chooses among them for reasons the label alone does not show.

Source: FDA National Drug Code Directory and Drugs@FDA, as summarized on each medicine's page. A dash means the fact is not on record.